Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's mentioned in the latest amended S-1/A filing on EDGAR, 10-8-19. Along with a description of the latest shares and warrants to be issued in order to raise $6 mil.
UK might add $20-30mm/yr depending on price negotiated with the health care system there. Just for burns.
Thanks Mony, there are approx. 10k inpatient burns in the UK annually, which is in line with US based on population.
Another major dilution and reverse split. If they announce raises for themselves it will be the trifecta.
Thanks, word's getting out, and the word is good.
For those easily excitable penny stock buyers, divide 6 million by 66 million. That's the nominal price buyers of this larest offering will be paying per share. Little less than where you are now. Good luck, hope you don't have kids.
Oh, not just the pooch, I forgot to mention shareholders.
General comment/question for all the bright folks here. Investing to me is as much about timing as anything (but should never start until due diligence is done). I've always been pretty good about knowing when to buy, my problem usually comes when it's time to sell. Although there have been a couple occasions when I passed on buying because a stock had already doubled in a short time and decided to wait only to see it quadruple or more from there. Anyone else have similar or different experience with this?
Spetch, think you got some pretty good answers. This is an early growth stock that many would still consider speculative (I don't, but that's just one man's opinion). It's not trading on fundamentals, but on future growth potential. So the trick is to get in early before the potential is realized but at the best price possible.
I finally have some more cash available since my 401K administrator (bastards at Merrill Lynch) will allow me to buy now that it's on NASDAQ and not the OTC. But I'm going to wait a bit. My concern at the moment is not with Avita but the overall market. Think it may be in for another leg down in which case people get margin calls and sell the good the bad and the ugly. But I also know I may end up having to buy it for 8.
Trading stocks actively can be rewarding. But it takes a tremendous amount of time and psychic energy and can be devastating when you step on a turd. Been there, done that.
In Avita's case if all they ever do is garner the market in the burn sector they are in currently they will have enough earnings to support a stock price in the mid to upper teens by mid to late next year. You could do worse.
Charlie and his friend have done pretty well over the past 60+ years. Berkshire has been one of my core holdings for the past 20 years, didn't start out as a lot, but it's done quite well by me. Be the last thing I sell.
Oh, uh, RCEL not AVMXY, forgot what happened Tuesday. Getting old I guess.
AVMXF appears to be trading at a premium to AVMXY at the moment. AVMXF holders might look at selling on the open market and buying AVMXY at a discount. Might be cheaper and simpler in the long run.
Thanks for that Jimmy, glad to hear it. Also glad I don't own any AVMXF.
Very recent post by Thomas on Yahoo message board I think is a pretty good description of the current status of AVMXF shares. Best to those who hold, hopefully it will all work out.
Response from the company on AVMXF shares:
Hello,
Those shares are not registered nor sanctioned by the company.
Caroline
Caroline V. Corner, PhD
Westwicke, an ICR Company
My apologies to the board, didn't intend to take up so much with this. Just letting people know they need to inform themselves.
AVMXF not AVMXY
Once after several posts urging holders of AMXY to contact Avita or their broker I said what I would do. Although I regret having said it, it is what I would do. You on the other hand, without knowing all the facts, have basically been telling people to do nothing. Even after it became clear that what you had been stating as a fact, that they would get 1 share of RCEL for 20 shares of AVMXY, was not the case. Starting to see why Tdeck has the opinion he has of you. That said, I will take the advice quoted at the bottom of your posts
Perhaps you might also.
Keep you are giving some incredibly nonchalant advice based on your assumptions, which to date have been incorrect. You've followed up some of my other posts elsewhere with similar comments. Once again I would simply urge people to contact the company, their broker or Bank Of New York to determine for themselves how best to protect their interests. It's not your or my money at risk, and if what Workin4aLivin's response from the company is accurate, there is definitely risk involved.
I don't enjoy seeing other people lose money. Hope it works out.
Check out Workin4aLivin's post on the Yahoo AVMXY message board. Not a reassuring response from the company. Whoever owns AVMXF shares should call or email the company to verify those shares current disposition. Sorry for being coy, but those shareholders need to figure out what they want to do on their own. They may have noticed AVMXF was still trading on the OTC today.
If you are holding AVMXF you may want to:
A. Call your broker
B. Dump your shares ASAP.
As it stands a complete non factor. The reason it's been a topic of discussion since MS announced acquisition of 130mm+ borrowed shares is that the primary use of borrowed shares is short sales. Since they've all been returned (at least for the moment) it's no longer an issue. Something to talk about for a few days.
Once again it seems to be a moot point. The Japanese entity that just filed the becoming a subtatial holder form just filed a ceasing to be a subtantial holder form. Think perhaps all those borrowed shares are back with their original owners. Weird 3 card Monte game. Just have to stay tuned to see if any more cards appear.
You are correct Mike, but I still won't be surprised if the big players don't try to shake the tree to get cheaper shares. They won't be getting mine, but I'll buy more if they do.
To any newbies to this board I'd advise tapping on Tdeck's handle. On the right side of the webpage that comes up tap on the number of posts link. Go back and read some of his older posts, it will help you in your own due diligence. He did some really good DD.
What jugs said.
Got my theories but I'm not an investment banker.
So it appears MS isn't finished with us yet. Transferred all those borrowed shares to a Japanese entity. Sheesh, pretty arcane stuff.
I'd call Avita IR first thing tomorrow. Wasn't mentioned, as I'm sure you know. I'd think they'd honor them at 20 to 1 RCEL, but maybe you'll have to sell and rebuy. I'd call the company or your broker, in that order.
More good news, Morgan Stanley returned all borrowed shares. They're done shorting. So my speculation about them being the MM was off base, but it was not something to get worked up about. They most likely closed their short positions. I was right about the uplisting date. Yea me. Good luck to all here.
StrataGraft not Statecraft. Smartphone my butt.
Thanks for that. My general but limited understanding of how markets work also. All I was trying to say initially is that there could be other reasons beyond simply shorting the stock that the MS transactions took place. Particularly due to the transparent way it took place, which is unusual. We'll see what unfolds.
What I do know for certain is that Avita is first to market with a new burn treatment that improves outcomes and lowers cost. Insurance companies will be selling Recell for them. They will have no competition for several years. The Statecraft product will have a niche, but no improvement in healing time or cost is indicated and Avita's outcomes are superior. There's a private company called
Xcel Biometrics that acquired product rights to a spray on or powder treatment developed at Wake Forest, but they've done nothing with it to date. And there's RCAR, a total joke. And they'll be first to market with other applications. So whatever the MS deal is, in the long run it's just noise.
Sorry for the long winded post, can't help myself sometimes.
Since you're response is to me I assume you are referring to me. If you've read this board for awhile you'd know I've consistently stated my own target of 10/sh late Q1 early Q2 2020. I've also stated I expected a pullback once the index rebalancing was done. Frankly I think the stock has been ahead of itself more often than not since this past March. I'd be fine with it at 5. Selling for me would just generate money for Uncle Sam since 90% of my shares are still short term.
My issue at the moment is all the speculation over the MS PR. For example, do we know for a fact all the recent short sales were by MS? Even then it's only 1.5% of outstanding. Whatever, helps the day go by. Best to you.
Uh, they have to return for the same price they borrowed them at, so if the price goes below that price and the lender calls the shares, they're on the hook for the difference. Not that difficult really. I promise not to share whatever I find if that would make you happy. You seem to be making a lot of assumptions as to what's going on here and representing them as fact. I don't purport to know and post what thoughts I have as conjecture since that's all they are at this point.
So can you tell me what prudent steps a Market Maker might take prior to the uplisting of an ADR they will be handling? Might they need access to borrowable shares to satisfy the needs of the market? This is conjecture, just a possibility among a few possibilities. Point is it's all conjecture at this point unless you are one of the primary entities involved.
The price when borrowed is the price they start losing money on when it goes below that price. Fairly pertinent IMO.
They purchased 11,569,567 AVH shares on the open market. Will come up with an average price when I have time later. Since the timing of the purchases and borrowings were roughly the same, purchase price should give rough idea of what price they borrowed the shares. Which in turn would tell me where a likely bottom might be.
It states in the lending agreements that MS gets the voting rights.
I expected a pull back once index rebalancing was done. I've also believed bigger players would try to shake out weaker hands around the uplisting to get cheaper shares. But this move by MS seems a little too transparent. Why not take a 4.9% position and not have to report it? And with lots of help from our major shareholders. Granted there isn't much reason to borrow shares other than shorting, but this move seems a bit odd. We'll see. I'm putting a GTC sell at 40 on all my shares. Luck to all.
Wonder if Morgan Stanley might be the primary MM for CELS. The machinations of making markets is above my pay grade. Honestly, I'd be ok with it going back to 5 after listing. Means I'd be able to buy another 20k shares. I'm in for the long haul.
Got to read the fine print. Its either a short or an arbitrage play or both. Ultimately the lender funds are keeping their shares.
Meant Cowen.